Neurobooth: A study of motor behavior using digital technologies
The purpose of this study is to create new digital tools to measure speech, movement, and cognition in people with and without neurological diseases. Our goal is to improve the accuracy of diagnosis and the ability to discover effective treatments.
Link to enroll: neurobooth.mgh.harvard.edu
About the Study
Eligible Ataxia Types
All Ataxias
Type of Study
Research Study
Clinical Trial Phase
N/A
Age Range
Adult 18+
Study Start Date
04/2022
Estimated Completion Date
N/A – Ongoing
IRB Approval #
2021P000257
Location(s)
Massachusetts General Hospital
15 Parkman Street
Boston, MA
Contact Information
Neurobooth Study Team
neurobooth@mgh.harvard.edu
Phone: 857-238-1520
What does participation in the study entail?
Participants will be guided through a 40-minute assessment that will measure their motor skills, eye movements, speech, and thinking using cameras and a microphone. During this time, participants will complete tasks on a computer and wear sensors on their bodies.
What are the potential benefits for participants?
There are no direct benefits, but your participation will help create new technologies to diagnose and measure neurological diseases and support the development of new treatments.
What are the potential risks for participants?
Potential risks could include loss of confidentiality and anxiety during the assessment.
Is there financial compensation?
Yes. $25 Amazon Gift Card.
Is there travel reimbursement?
No.
Who is eligible?
People who are willing to travel to Boston for the in-person assessment, have a known or possible neurologic condition, have a family history of ataxia, are healthy individuals, and are at least 14 years of age. People with and without symptoms are eligible. We want to develop tools that can detect and measure the earliest signs of ataxia.
View Other Research Opportunities
To Test or Not to Test: Exploring Predictive Genetic Testing Decision Making in Individuals with a Family History of Hereditary Ataxia
Our research goal is to further explore the factors influencing participants’ predictive genetic testing decision-making for hereditary ataxia. We will achieve this by interviewing participants who declined genetic testing as Read More…
Monogenic and Polygenic Risk Prediction for Individuals
MyOme Inc. is a health technology company focused on using genetic testing to help people understand their health risks before problems start. In this study, MyOme is testing a new Read More…
Safety, Empowerment, and Dignity: Improving the Airport Journey of Customers Using Wheelchairs
InterVISTAS is currently collaborating with Indiana University – Bloomington (IUB) to collect information on the air travel experiences of people with disabilities. This project strives to identify ways to enhance Read More…
